Cargando…
The Clinical and Economic Impact of Employees Who Are Care Partners of Patients with Multiple Sclerosis by Disease Severity
Background: Research on employee care partners of patients with multiple sclerosis (MS) is limited. Objectives: The clinical and economic impact on employee care partners was evaluated by MS disease severity. Methods: Employees with spouses/domestic partners with MS from the Workpartners database (J...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Columbia Data Analytics, LLC
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10105615/ https://www.ncbi.nlm.nih.gov/pubmed/37069893 http://dx.doi.org/10.36469/001c.57593 |
_version_ | 1785026248859189248 |
---|---|
author | Hendin, Barry Brook, Richard A. Beren, Ian A. Kleinman, Nathan Fink, Cindy Phillips, Amy L. Lobo, Carroline |
author_facet | Hendin, Barry Brook, Richard A. Beren, Ian A. Kleinman, Nathan Fink, Cindy Phillips, Amy L. Lobo, Carroline |
author_sort | Hendin, Barry |
collection | PubMed |
description | Background: Research on employee care partners of patients with multiple sclerosis (MS) is limited. Objectives: The clinical and economic impact on employee care partners was evaluated by MS disease severity. Methods: Employees with spouses/domestic partners with MS from the Workpartners database (Jan. 1, 2010–Dec. 31, 2019) were eligible if: spouse/partner had at least 3 MS-related (ICD-9-CM/ICD-10-CM:340.xx/G35) inpatient/outpatient/disease-modifying therapy claims within 1 year (latest claim = index date); 6-month pre-index/1-year post-index enrollment; and age 18 to 64 years. Employee care partners’ demographic/clinical characteristics and direct/indirect costs were compared across predetermined MS severity categories. Logistic and generalized linear regression modeled the costs. Results: Among 1041 employee care partners of patients with MS, 358 (34.4%) patients had mild MS, 491 (47.2%) moderate, and 192 (18.4%) severe. Mean (standard error [SE]) employee care partner age was 49.0 (0.5) for patients with mild disease, 50.5 (0.4) for moderate, 51.7 (0.6) for severe; percent female care partners was 24.6% [2.3%] mild, 19.8% [1.8%] moderate, 27.6% [3.2%] severe; and mean care partner Charlson Comorbidity Index scores 0.28 (0.05) mild, 0.30 (0.04) moderate, 0.27 (0.06) severe. More care partners of patients with moderate/severe vs mild MS had hyperlipidemia (32.6%/31.8% vs 21.2%), hypertension (29.5%/29.7% vs 19.3%), gastrointestinal disease (20.8%/22.9% vs 13.1%), depression (9.2%/10.9% vs 3.9%), and anxiety 10.6%/8.9% vs 4.2%). Adjusted mean medical costs were greater for employee care partners of patients with moderate vs mild/severe disease (P<.001). Pharmacy costs (SE) were lower for employee care partners of mild vs severe/moderate patients (P<.005). Sick leave costs (SE) were greater for employee care partners of mild/severe vs moderate patients (P<.05). Discussion: Employee care partners of patients with moderate/severe vs mild MS had more comorbidities (ie, hypertension, gastrointestinal disease, depression, and anxiety) and higher pharmacy costs. Employee care partners of patients with moderate vs mild/severe MS had higher medical and lower sick leave costs. Treatment strategies that improve patient outcomes may reduce employee care partner burden and lower costs for employers in some instances. Conclusions: Comorbidities and direct/indirect costs of employees whose spouses/partners have MS were considerable and varied with MS severity. |
format | Online Article Text |
id | pubmed-10105615 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Columbia Data Analytics, LLC |
record_format | MEDLINE/PubMed |
spelling | pubmed-101056152023-04-16 The Clinical and Economic Impact of Employees Who Are Care Partners of Patients with Multiple Sclerosis by Disease Severity Hendin, Barry Brook, Richard A. Beren, Ian A. Kleinman, Nathan Fink, Cindy Phillips, Amy L. Lobo, Carroline J Health Econ Outcomes Res Neurological Diseases Background: Research on employee care partners of patients with multiple sclerosis (MS) is limited. Objectives: The clinical and economic impact on employee care partners was evaluated by MS disease severity. Methods: Employees with spouses/domestic partners with MS from the Workpartners database (Jan. 1, 2010–Dec. 31, 2019) were eligible if: spouse/partner had at least 3 MS-related (ICD-9-CM/ICD-10-CM:340.xx/G35) inpatient/outpatient/disease-modifying therapy claims within 1 year (latest claim = index date); 6-month pre-index/1-year post-index enrollment; and age 18 to 64 years. Employee care partners’ demographic/clinical characteristics and direct/indirect costs were compared across predetermined MS severity categories. Logistic and generalized linear regression modeled the costs. Results: Among 1041 employee care partners of patients with MS, 358 (34.4%) patients had mild MS, 491 (47.2%) moderate, and 192 (18.4%) severe. Mean (standard error [SE]) employee care partner age was 49.0 (0.5) for patients with mild disease, 50.5 (0.4) for moderate, 51.7 (0.6) for severe; percent female care partners was 24.6% [2.3%] mild, 19.8% [1.8%] moderate, 27.6% [3.2%] severe; and mean care partner Charlson Comorbidity Index scores 0.28 (0.05) mild, 0.30 (0.04) moderate, 0.27 (0.06) severe. More care partners of patients with moderate/severe vs mild MS had hyperlipidemia (32.6%/31.8% vs 21.2%), hypertension (29.5%/29.7% vs 19.3%), gastrointestinal disease (20.8%/22.9% vs 13.1%), depression (9.2%/10.9% vs 3.9%), and anxiety 10.6%/8.9% vs 4.2%). Adjusted mean medical costs were greater for employee care partners of patients with moderate vs mild/severe disease (P<.001). Pharmacy costs (SE) were lower for employee care partners of mild vs severe/moderate patients (P<.005). Sick leave costs (SE) were greater for employee care partners of mild/severe vs moderate patients (P<.05). Discussion: Employee care partners of patients with moderate/severe vs mild MS had more comorbidities (ie, hypertension, gastrointestinal disease, depression, and anxiety) and higher pharmacy costs. Employee care partners of patients with moderate vs mild/severe MS had higher medical and lower sick leave costs. Treatment strategies that improve patient outcomes may reduce employee care partner burden and lower costs for employers in some instances. Conclusions: Comorbidities and direct/indirect costs of employees whose spouses/partners have MS were considerable and varied with MS severity. Columbia Data Analytics, LLC 2023-04-13 /pmc/articles/PMC10105615/ /pubmed/37069893 http://dx.doi.org/10.36469/001c.57593 Text en https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (4.0) (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Neurological Diseases Hendin, Barry Brook, Richard A. Beren, Ian A. Kleinman, Nathan Fink, Cindy Phillips, Amy L. Lobo, Carroline The Clinical and Economic Impact of Employees Who Are Care Partners of Patients with Multiple Sclerosis by Disease Severity |
title | The Clinical and Economic Impact of Employees Who Are Care Partners of Patients with Multiple Sclerosis by Disease Severity |
title_full | The Clinical and Economic Impact of Employees Who Are Care Partners of Patients with Multiple Sclerosis by Disease Severity |
title_fullStr | The Clinical and Economic Impact of Employees Who Are Care Partners of Patients with Multiple Sclerosis by Disease Severity |
title_full_unstemmed | The Clinical and Economic Impact of Employees Who Are Care Partners of Patients with Multiple Sclerosis by Disease Severity |
title_short | The Clinical and Economic Impact of Employees Who Are Care Partners of Patients with Multiple Sclerosis by Disease Severity |
title_sort | clinical and economic impact of employees who are care partners of patients with multiple sclerosis by disease severity |
topic | Neurological Diseases |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10105615/ https://www.ncbi.nlm.nih.gov/pubmed/37069893 http://dx.doi.org/10.36469/001c.57593 |
work_keys_str_mv | AT hendinbarry theclinicalandeconomicimpactofemployeeswhoarecarepartnersofpatientswithmultiplesclerosisbydiseaseseverity AT brookricharda theclinicalandeconomicimpactofemployeeswhoarecarepartnersofpatientswithmultiplesclerosisbydiseaseseverity AT bereniana theclinicalandeconomicimpactofemployeeswhoarecarepartnersofpatientswithmultiplesclerosisbydiseaseseverity AT kleinmannathan theclinicalandeconomicimpactofemployeeswhoarecarepartnersofpatientswithmultiplesclerosisbydiseaseseverity AT finkcindy theclinicalandeconomicimpactofemployeeswhoarecarepartnersofpatientswithmultiplesclerosisbydiseaseseverity AT phillipsamyl theclinicalandeconomicimpactofemployeeswhoarecarepartnersofpatientswithmultiplesclerosisbydiseaseseverity AT lobocarroline theclinicalandeconomicimpactofemployeeswhoarecarepartnersofpatientswithmultiplesclerosisbydiseaseseverity AT hendinbarry clinicalandeconomicimpactofemployeeswhoarecarepartnersofpatientswithmultiplesclerosisbydiseaseseverity AT brookricharda clinicalandeconomicimpactofemployeeswhoarecarepartnersofpatientswithmultiplesclerosisbydiseaseseverity AT bereniana clinicalandeconomicimpactofemployeeswhoarecarepartnersofpatientswithmultiplesclerosisbydiseaseseverity AT kleinmannathan clinicalandeconomicimpactofemployeeswhoarecarepartnersofpatientswithmultiplesclerosisbydiseaseseverity AT finkcindy clinicalandeconomicimpactofemployeeswhoarecarepartnersofpatientswithmultiplesclerosisbydiseaseseverity AT phillipsamyl clinicalandeconomicimpactofemployeeswhoarecarepartnersofpatientswithmultiplesclerosisbydiseaseseverity AT lobocarroline clinicalandeconomicimpactofemployeeswhoarecarepartnersofpatientswithmultiplesclerosisbydiseaseseverity |